JAK and PI3K Signaling Pathway Markets

Apr 2014| PHM168A| BCC Publishing

Report Highlights

The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the global market for signal transduction therapies and inhibitors
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018
  • Information on approved products such as Ruxolitnib, as well as others in devlopment
  • Discussion of the regulatory environment which is impacting development
  • Relevant patent analysis
  • Profiles of leading companies in the industry

SCOPE OF THE STUDY

BCC Research conducted the market evaluation, the global and regional breakdown of sales data, present and prospective application of the therapies, market forecasting, success and challenges, patent details, regulatory facet, clinical developments, market leaders and market share of the maturing market for JAK and PI3K inhibitors/therapies/biomarkers.

The sales data for the global and regional markets is validated for the present and projected values through scientific and statistical analysis. The information regarding the approved products and candidates as well as the technologies/platforms are provided based on their present/prospective application and viability.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter Name Pages Price Member Price
Full Report: JAK and PI3K Signaling Pathway Markets 143 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3$250Free
Chapter- 3: OVERVIEW30$577Free
Chapter- 4: REGULATORY ASPECTS7$135Free
Chapter- 5: NEW DEVELOPMENTS19$365Free
Chapter- 6: MARKET ANALYSIS-SIGNAL TRANSDUCTION THERAPIES (JAK AND PI3K)24$462Free
Chapter- 7: PATENT ANALYSIS14$269Free
Chapter- 8: CURRENT SITUATION 6$115Free
Chapter- 9: COMPANY PROFILES33$635Free
Chapter- 10: APPENDIX I-ABBREVIATIONS3$58Free
Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Biorefinery Technologies: Global Markets

The global market for biorefinery technologies reached $342.8 billion in 2012. This market is expected to grow to $387.8 billion in 2013 and $700.7 billion in 2018 with a compound annual growth rate (CAGR) of 12.6% for the five-year period, 2013 to 2018.

Edward Gobina | Nov 2013

Environmental Markets for Biotechnology

U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

Jon Evans | Aug 2013

Kinase Inhibitors: Global Markets

The global kinase inhibitors market reached $28.1 billion in 2010 and nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.

Shalini Shahani Dewan | Jun 2012

Global Markets for Enzyme Inhibitors

The global market for enzyme inhibitors was valued at $104.4 billion in 2010 and reached nearly $104.6 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 4% and reach nearly $127.4 billion by 2016.

Shalini Shahani Dewan | Jun 2012

Share This Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype.

Contact
© 2020 BCC Research
Privacy Policy |Site Map|Terms & Conditions